Vista Health Pte Ltd

Ahead of Rare Disease Day on 28th February, Rare Disorders Society (Singapore) recently held a series of events to raise awareness of patients’ journeys, key gaps in access to diagnostics and medicines, and pragmatic ways to ease the burden on patients and caregivers. The Carry Hope 2025 Forum, attended by Dafydd Green and Will Brown, brought together researchers, healthcare professionals, policymakers, and families to discuss key topics and updates with rare disases. Wee Seng PHUA highlighted RDSS’s achievements in raising awareness for a wide range of rare diseases in Singapore and building important links with various stakeholders. Guest of Honour Jasmin Lau then shared the Ministry of Health (Singapore)'s perspective on the challenges of rare disease support while underscoring the need for equity in funding decisions. Inspirational talks were also given by speakers including Yoong Khean Khoo, Saumya Jamuar and Yong Hao Lim, all highlighting the opportunities to advance rare disease diagnosis, care, and advocacy. The following Saturday, members of the #VistaHealth team participated in the Carry Hope Walk and Run—an event that has grown significantly in recent years and helps ensure that rare diseases are no longer a hidden burden in Singapore. The team braved the rain to complete the course and was motivated by the carnival energy and optimism to carry hope. Thank you once again to RDSS for organizing this event and for continuing to inspire hope for all of us committed to supporting rare diseases. #LoveIsNotRare #CarryHopeRDSS #LightUpForRare #RDSSCommunity #WhatAreRareDiseases #RDSSAwareness #SupportInclusion #CelebrateAbilities #RareDiseases #RareDisordersSocietySG #RDSS

The 2nd Malaysian Society of Patient Blood Management (MyPBM) (#MyPBM) Scientific Conference recently brought together regional and global experts to create a “Recipe for Optimal Blood Health", the theme of this year’s conference. #VistaHealth attended as sponsor and knowledge partner.  In officially opening the conference, Head of the Ministry Of Health, Malaysia (KKM), YB Datuk Seri Dr. Dzulkefly Ahmad reaffirmed Malaysia’s commitment to supporting the implementation of #PatientBloodManagement (#PBM) through a PBM Task Force established under the Ministry. The PBM Task Force promotes the responsible use of blood transfusions, with the aim of reducing the risk of complications from unnecessary transfusions and potentially saving an estimated 1,250 bags of blood and RM1.25 million each day. Across the three days, distinguished speakers from Australia, India, Japan, South Korea and the United States discussed their experiences in PBM and performing bloodless surgeries across various therapeutic areas. Strategies to achieve this included optimising pre-operative haemoglobin levels, using minimally invasive techniques, and optimising patients’ tolerance to anaemia. The importance of alignment between surgeons and anaesthesiologists was also emphasised, while respecting patients’ choice of treatment. Other key topics included results from a study on the cost-effectiveness of PBM, the forthcoming World Health Organization's (#WHO) guidance on PBM, and the role of innovations such as #ArtificialIntelligence (#AI) and point-of-care testing (#POCT) in PBM implementation. Renowned experts Dr. Aryeh Shander and Sherri Ozawa, MSN, RN also addressed the challenges, ethical considerations, and strategies for optimising PBM and blood health.   The conference also marked the official launch of the first-ever 24-hour Global Anemiathon, led by World Anemia Awareness, which brought together global experts to share insights on #anaemia, iron deficiency, blood health, and PBM practices. Watch this space for a post-conference report by MyPBM and Vista Health!  In the meantime, Vista Health would like to congratulate MyPBM on the success of the conference and extend our heartiest gratitude to all speakers, sponsors and participants. Together, let’s raise our hands for blood health!  #ValueBasedHealthcare #PatientCare #BloodManagement #HealthPolicy

February 13th is #WorldAnaemiaAwarenessDay. #Anaemia remains a global health challenge, affecting 1 in 4 people worldwide, with a high prevalence among young children and women of reproductive age. This day aims to educate all on the ideal haemoglobin level, which is above 13g/dL, as these levels are crucial for maintaining optimal blood health. Anaemia is also a major concern in surgical care, with 39% of pre-operative patients affected and up to 90% of post-operative patients experiencing it after major surgery. While blood transfusions are often the default treatment for anaemia, they are not always the most appropriate option and can pose serious risks, including acute respiratory distress syndrome and increased hospital mortality. On this World Anaemia Awareness Day, we emphasise the critical role of #PatientBloodManagement (#PBM) – a patient-centred, systematic, evidence-based approach to improve patient outcomes by managing and preserving patients’ own blood, while promoting patient safety and empowerment. In August 2024, #VistaHealth conducted a survey among the general population in Singapore, Malaysia, and the United Kingdom, revealing significant knowledge gaps regarding blood transfusions, their management and overuse in elective surgeries. Upon learning the facts, many respondents expressed concerns about the increased mortality risk and the frequent occurrence of unnecessary transfusions. Encouragingly, there was a strong willingness among the public to participate in PBM initiatives, especially if it contributed to reducing the risk of prolonged hospital stays. These insights highlight the importance of strengthening PBM implementation and closing existing knowledge gaps to promote safer and more effective blood management practices. Beyond improved patient outcomes, effective PBM can also reduce healthcare costs and enhance operational efficiencies. To learn more about our work in PBM, feel free to contact us at info@vista.health or find us at the 2nd Malaysian Society of Patient Blood Management Scientific Conference (https://lnkd.in/d2x3iA93), taking place in Kuala Lumpur from 13th – 15th February 2025. #healthcare #vistahealth

This week, members of the #VistaHealth team will be attending the 2nd Asia Pacific Immunization Coalition (APIC) - Asia Dengue Voice & Action (ADVA) Group Summit, one of the Asia-Pacific’s premier meetings dedicated to #vaccine policy shaping, #PandemicPreparedness, and #HealthSecurity. Vista Health has worked extensively across various #InfectiousDiseases, including #Covid19, #dengue, #malaria, #HIV, and #RSV, and as such has focused on disease mitigation strategies across various disciplines. As the Knowledge Partner for ADVA, we also help run the Asia Dengue Policy Working Group, which will have a booth at the event. In an unpredictable year for infectious disease control, the APIC Summit will serve as a key platform to discuss critical topics, including containing the spread of #mpox, introducing novel disease monitoring methods such as #WastewaterSurveillance, optimising #vaccination approaches, and developing programmes for RSV control. If you are attending the event or would like to learn more about the key themes discussed, please connect with Anthony Morton-Small, Dafydd Green, Will Brown, or Rie Tai. Alternatively, you can reach out to info@vista.health. We look forward to seeing you there!

#VistaHealth will play a key role as sponsor and knowledge partner for the upcoming 2nd Malaysian Society of Patient Blood Management (MyPBM) Scientific Conference in Kuala Lumpur, taking place from 13th – 15th February 2025. The event brings together leading global experts, clinicians and academics to explore strategies and innovations in #PatientBloodManagement (#PBM). Attendees will have the opportunity to gain insights into multi-disciplinary research and practical implementation, including the role of #ArtificialIntelligence (#AI) in PBM. At Vista Health, we work closely with #patients, policymakers and healthcare professionals across #Asia and #Europe to understand and implement evidence-based PBM models that are designed to improve clinical outcomes whilst reducing care provision costs and maximising health system efficiency. If you are attending the event, feel free to connect with Joe Caputo, Tim Cushway and Rui Min FUNG to explore opportunities for optimising PBM. Event registration is still open via the link https://lnkd.in/d2x3iA93.

As we welcome the Year of the Snake, we wish our partners, clients, and friends across the globe prosperity, health, and happiness 🐍🍊🧧🏮 At Vista Health, we’re committed to delivering value-based healthcare solutions that empower professionals and improve lives—this year and beyond. Let’s make 2025 a year of growth and collaboration together!    #LunarNewYear #HappyNewYear #VistaHealth 

As part of the continued expansion of the #VistaHealth business we are delighted to announce the opening of our new office in #HongKong. We are excited to better serve our existing Hong Kong-based clients and those seeking to take advantage of the opportunities presented by Hong Kong and the #GreaterBayArea. For more information on how we can support you, please contact Mungo Paterson, Judy YT Li, or Bruce Crawford.  

Recently there have been reports of outbreaks of the #HumanMetapneumovirus (#HMPV), raising questions about #PandemicPreparedness globally. Since December 2024, rising hMPV cases in #China and emerging cases in #India and #Malaysia have highlighted the risks to vulnerable populations. Although hMPV typically causes mild symptoms such as cough, fever, and nasal congestion, it can lead to severe respiratory illnesses like bronchitis or pneumonia, particularly in young children, older adults, and those with weakened immune systems (e.g., #cancer and #transplant patients, as well as older adults). The World Health Organization (#WHO) has stated that current hMPV transmission patterns are consistent with typical winter trends and do not indicate an abnormal outbreak. Former WHO Chief Scientist Soumya Swaminathan noted, “[hMPV] is a known virus that causes respiratory infections, mostly mild,” and cases in China are now declining after control measures took effect. Discovered in 2001, hMPV currently has no vaccines or specific antiviral treatments. However, researchers are leveraging knowledge from similar Paramyxoviridae family viruses like #RespiratorySyncitialVirus (#RSV) to develop solutions. Moderna’s ongoing Rhyme Trial (https://lnkd.in/gg3pnDki) is testing an investigational combination #mRNA #vaccine for RSV and hMPV in infants aged 5 to 24 months. This vaccine uses the same mechanism as #COVID-19 mRNA vaccines, instructing the body to produce a protein that targets prefusion F-protein neutralising epitopes, helping the immune system protect against the virus. AstraZeneca’s subsidiary Icosavax is also advancing IVX-A12 to Phase III trials. This RSV and hMPV combination vaccine uses a protein virus-like particle platform and has shown positive Phase II trial results among older adults aged 60 to 85 years. These advancements, though in development, offer a promising step toward mitigating hMPV’s effects across age groups, especially for vulnerable populations. Reflecting on the COVID-19 pandemic, it is unsurprising that rising hMPV cases raise public concern. COVID-19 showed how swiftly outbreaks can strain healthcare systems, underscoring the need for proactive pandemic responses. Advances in #diagnostics like multiplex-PCR panels and vaccine technology offer opportunities to combat infectious diseases like hMPV. Beyond innovation, governments must prioritise public health strategies to reassure communities, prevent panic, and foster trust in resilient health systems. Vista Health is closely monitoring the hMPV situation, offering updates and insights through an infectious disease lens. Follow our page for the latest developments and expert perspectives, or contact info@vista.health to discuss our infectious disease work further.

Vista Health hosted an in-person breakfast roundtable to discuss the challenges and opportunities related to AI use in the health care industry. The session included a keynote presentation and panel discussion featuring cross-industry experts. The event discussed themes important to the future adoption of AI: ✅ AI in frontline provider care: ☀️ Applications of AI in healthcare, such as detecting medical conditions, and generating treatment plans, providing assistant support to clinicians, and improving healthcare worker productivity  ☀️ Leveraging AI to provide medical care in remote and underserved areas, and raising patient access  ✅ Using AI for competitive advantage: ☀️ Using AI to improve efficiency and productivity in areas such as sales and inventory management  ☀️ AI enablement of smart/digital products and devices ✅ Challenges in AI adoption and overcoming resistance: ☀️ The importance of building AI literacy and change management to ensure successful adoption of AI systems  ☀️ Strategies for building internal AI capabilities through hands-on experimentation and showcasing early success stories ✅ Balancing internal and external AI capabilities: ☀️ Approaches to using external vendors for prototyping and scaling, while building internal AI expertise  ☀️ Considerations around the need to build de novo algorithms, and instead use and fine tune open-source models ✅ Ethics, environmental impact and sustainability of AI: ☀️ Challenges around the energy consumption and environmental impact of AI and the potential benefits of AI in reducing carbon footprint through remote work and efficient work streams  ☀️ Considerations around the ethical use of AI and the importance of governance frameworks to ensure its appropriate use ✅ AI strategy and long-term planning: ☀️ The importance of government agencies and organiszations investing in building internal AI teams and technical skills.  ☀️ Developing a strategic, long-term approach to AI implementation, funding and governance frameworks We would like to thank our experts for their participation and sharing their experiences of using AI within their day-to-day working life. At our next event in February, we will be launching an exciting partnership to bring AI-powered solutions to our life sciences customers. If you are interested in attending, please do contact Mungo Paterson for more information. To learn more about what was discussed at the event and how Vista Health can support in your AI journey, please visit vista.health or contact us at info@vista.health.     #VistaHealth #AI #ArtificialIntelligence #Healthcare #Strategy #Sustainability #Environmental #Strategy #Patient #PatientAccess #Data

Merry Christmas and Happy New Year from Vista Health! As 2024 comes to a close, we want to take a moment to reflect on the incredible journey we've had this year. We extend our heartfelt thanks to our clients, partners, and team for an exceptional year. Wishing you a joyful holiday season and a prosperous New Year. Here's to continued success in 2025! #VistaHealth #MerryChristmas #HappyNewYear